SCHEMBL23830158

SCHEMBL23830158

Cc1nccnc1-c1c(C(N)=O)nnn1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.41
▸ PABPC1 P11940 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CA1 P00915 6/20 0.37
▸ CA2 P00918 6/20 0.37
▸ CA4 P22748 6/20 0.37
▸ CA9 Q16790 6/20 0.37
▸ ADORA2A P29274 2/20 0.35
▸ ADORA1 P30542 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ ADORA2B P29275 1/20 0.35
▸ KAT2B Q92831 1/20 0.35
▸ PIM3 Q86V86 2/20 0.33
▸ PIM2 Q9P1W9 1/20 0.33
▸ CCNA2 P20248 2/20 0.32
▸ CDK2 P24941 2/20 0.32
▸ CCNA1 P78396 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23830181 0.78 MKNK1 (0.50) MEN1PABPC1KMT2ACA1CA2
SCHEMBL14154662 0.70 ALDH1A1 (0.52) MEN1PABPC1KMT2ACA1CA2
SCHEMBL14154659 0.69 MEN1 (0.45) MEN1PABPC1KMT2ACA1CA2
SCHEMBL1463944 0.68 MKNK1 (0.42) MEN1PABPC1KMT2AADORA2AADORA1
SCHEMBL2310300 0.68 MKNK1 (0.42) MEN1PABPC1KMT2AADORA2AADORA1
SCHEMBL23830215 0.68 MKNK1 (0.39) MEN1PABPC1KMT2ACA1CA2
SCHEMBL14154660 0.68 CA1 (0.55) MEN1PABPC1KMT2ACA1CA2
SCHEMBL23088486 0.67 CCR1 (0.47) MEN1PABPC1KMT2ACA1CA2
SCHEMBL14154661 0.66 ALDH1A1 (0.49) CA1CA2CA4CA9LMNA
SCHEMBL14982037 0.65 MEN1 (0.45) MEN1PABPC1KMT2AADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240076286-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2024-03-07 — — US disclosed
US-20240002363-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2024-01-04 — — US disclosed
US-11760745-B2 Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-09-19 — — US disclosed
US-20210292301-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-09-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292301-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS KLKB1, KLK5, KLK1 MEN1 1404/4885PABPC1 3944/4885KMT2A 227/4885
US-11760745-B2 Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors KLKB1, KLK5, KLK1 MEN1 1404/4885PABPC1 3944/4885KMT2A 227/4885
US-20240002363-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS KLKB1, KLK5, KLK1 MEN1 1404/4885PABPC1 3944/4885KMT2A 227/4885
US-20240076286-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS KLKB1, KLK5, KLK1 MEN1 1404/4885PABPC1 3944/4885KMT2A 227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback